Valentin Fuster Selected Research

Aneurysm (Aneurysms)

10/2014	Thoracic aortic aneurysm and dissection.
12/2011	In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging.
1/2006	The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model.
8/2005	Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model.
2/2005	A canine model to study the significance and hemodynamics of type II endoleaks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentin Fuster Research Topics

Disease

62	Atherosclerosis 01/2024 - 06/2002
41	Atherosclerotic Plaque (Atheroma) 10/2023 - 02/2002
40	Myocardial Infarction 01/2023 - 11/2002
39	Inflammation (Inflammations) 10/2023 - 04/2004
37	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 05/2003
29	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 07/2003
25	Heart Failure 03/2024 - 09/2005
22	Hypertension (High Blood Pressure) 11/2023 - 09/2007
22	Thrombosis (Thrombus) 10/2022 - 11/2002
19	Diabetes Mellitus 01/2022 - 07/2007
18	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2004
18	ST Elevation Myocardial Infarction 01/2021 - 05/2003
17	Infarction (Infarctions) 11/2020 - 03/2011
16	Atrial Fibrillation 01/2023 - 12/2007
16	Hemorrhage 01/2021 - 01/2004
16	Acute Coronary Syndrome 05/2017 - 02/2002
12	COVID-19 01/2023 - 01/2020
12	Stroke (Strokes) 01/2023 - 08/2011
11	Heart Valve Diseases (Valvular Heart Disease) 01/2021 - 03/2010
10	Cardiomyopathies (Cardiomyopathy) 03/2024 - 11/2014
10	Pathologic Constriction (Stenosis) 01/2023 - 05/2004
9	Fibrosis (Cirrhosis) 01/2021 - 07/2011
8	Type 2 Diabetes Mellitus (MODY) 06/2023 - 02/2003
8	Ischemia 01/2021 - 08/2013
7	Myocarditis (Carditis) 03/2024 - 11/2015
7	Rupture 01/2021 - 05/2002
6	Dementia (Dementias) 03/2024 - 01/2020
6	Thromboembolism 03/2024 - 05/2012
6	Congenital Heart Defects (Congenital Heart Defect) 03/2024 - 01/2018
6	Left Ventricular Dysfunction 11/2020 - 04/2007
6	Neointima 10/2014 - 04/2003
5	Aortic Valve Stenosis (Aortic Stenosis) 06/2023 - 01/2004
5	Reperfusion Injury 01/2023 - 03/2011
5	Aneurysm (Aneurysms) 10/2014 - 02/2005
5	Vascular Diseases (Vascular Disease) 06/2010 - 03/2006
4	Ventricular Tachycardia 01/2024 - 08/2020
4	Insulin Resistance 11/2023 - 12/2004
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 12/2017
4	Ventricular Remodeling 01/2023 - 12/2011
4	Cardiotoxicity 01/2022 - 11/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 02/2015
4	Chronic Renal Insufficiency 05/2020 - 09/2013
4	Hypoxia (Hypoxemia) 01/2015 - 08/2013
4	Peripheral Arterial Disease 06/2008 - 03/2006
4	Hypercholesterolemia 05/2008 - 12/2002
3	Pulmonary Embolism 01/2023 - 01/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2019

Drug/Important Bio-Agent (IBA)

43	LipidsIBA 03/2024 - 02/2002
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
16	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2002
15	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021 - 06/2007
14	LDL CholesterolIBA 01/2024 - 07/2003
14	CholesterolIBA 01/2021 - 07/2003
12	oxidized low density lipoproteinIBA 01/2024 - 06/2008
12	CalciumIBA 12/2023 - 03/2009
9	Apolipoproteins E (ApoE)IBA 01/2024 - 06/2002
9	omega-Chloroacetophenone (Mace)IBA 01/2022 - 04/2009
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2003
9	CollagenIBA 01/2020 - 09/2003
9	Thromboplastin (Tissue Factor)IBA 10/2014 - 02/2003
8	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 07/2012
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 06/2008
8	Proteins (Proteins, Gene)FDA Link 10/2018 - 09/2003
7	GadoliniumIBA 01/2024 - 09/2005
7	C-Reactive ProteinIBA 10/2023 - 07/2004
7	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 01/2004
7	Hemoglobins (Hemoglobin)IBA 11/2019 - 01/2007
7	Contrast MediaIBA 09/2010 - 11/2004
6	ApolipoproteinsIBA 01/2024 - 06/2002
6	empagliflozinIBA 01/2023 - 01/2019
6	Phenobarbital (Luminal)FDA Link 03/2013 - 09/2003
5	Amyloid (Amyloid Fibrils)IBA 06/2023 - 01/2018
5	AnticoagulantsIBA 01/2023 - 08/2011
5	Thrombin FDA Link 01/2020 - 07/2004
5	Clopidogrel (Plavix)FDA Link 10/2017 - 05/2003
5	Warfarin (Coumadin)FDA LinkGeneric 05/2015 - 01/2004
5	HaptoglobinsIBA 11/2012 - 01/2007
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024 - 05/2015
4	Anti-Arrhythmia AgentsIBA 05/2022 - 01/2011
4	TroponinIBA 01/2021 - 01/2015
4	HDL CholesterolIBA 12/2020 - 07/2003
4	Troponin IIBA 11/2020 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 10/2004
4	HDL LipoproteinsIBA 01/2014 - 12/2004
4	Simvastatin (Zocor)FDA LinkGeneric 01/2012 - 02/2004
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2011 - 03/2008
4	Scavenger Receptors (Scavenger Receptor)IBA 09/2009 - 09/2006
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023 - 11/2002
3	AnthracyclinesIBA 01/2022 - 01/2019
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 04/2011

Therapy/Procedure

61	Therapeutics 01/2024 - 02/2002
27	Percutaneous Coronary Intervention 10/2022 - 10/2004
14	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020 - 02/2013
9	Secondary Prevention 01/2024 - 05/2003
9	Stents 10/2022 - 02/2005
5	Drug Therapy (Chemotherapy) 01/2022 - 06/2008
5	Drug-Eluting Stents 01/2019 - 12/2012
5	Catheter Ablation 11/2012 - 04/2008
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2024 - 02/2006
3	Thrombectomy 01/2023 - 03/2013